CIRM. 2012c.*Grant making process. CIRM’s response to IOM’s data request: Document(s) that outline the grants review process (from concept to award approval) (dated April 30, 2012).

CIRM. 2012d.*Disease teams awards update—March 2012. CIRM’s response to IOM’s data request: Information about the interim reviews of the disease teams (dated March 14, 2012).

CIRM. 2012e. Research Funding Strategy: ICOC Board Meeting (March 21, 2012), agenda item #9. http://www.cirm.ca.gov/files/meetings/pdf/2012/032112_item_9_funding_strategy.pdf (accessed November 28, 2012).

CIRM. 2012f. Stem cell agency commits $150 million to develop new therapies. http://www.cirm.ca.gov/PressRelease_2012-07-26 (accessed August 28, 2012).

CIRM. 2012g.*The response from the Grants Working Group (GWG) represents the scientific GWG members only. CIRM’s response to IOM’s data request: Questions for working groups (dated May 29, 2012) (accessed October 19, 2012).

CIRM. 2012h.* Update of details of extraordinary petitions. CIRM’s response to IOM’s data request: Details of extraordinary petitions. How many were there, how many were successful, in what tier were they before the petition was made, who are the investigators. (dated October 22, 2012).

CIRM. 2012i. RFA 12-03: CIRM hiPSC derivation award. http://www.cirm.ca.gov/RFA/rfa-12-03-cirm-hipsc-derivation-award (accessed August 28, 2012).

EAP (External Advisory Panel). 2010. Report of the External Advisory Panel. http://www.cirm.ca.gov/files/PDFs/Administrative/CIRM-EAP_Report.pdf (accessed September 4, 2012).

IOM (Institute of Medicine). 2012a.*Conversation with former director of Cancer Stem Cell Consortium in Canada. Institute of Medicine Committee on a Review of the California Institute for Regenerative Medicine open call on June 7, 2012.

IOM. 2012b.*Conversation with Director of the NIH Intramural Center for Regenerative Medicine. Institute of Medicine Committee on a Review of the California Institute for Regenerative Medicine open call on June 8, 2012.

IOM. 2012c.*Conversation with CIRM’s international partners in Germany. IInstitute of Medicine Committee on a Review of the California Institute for Regenerative Medicine open call on July 5, 2012.

IOM. 2012d.*Questionnaire for CIRM principal investigators. Institute of Medicine Committee on a Review of the California Institute for Regenerative Medicine Online Questionnaire launched on February 8, 2012.

IOM. 2012e.*Conversation with CIRM’s ICOC member regarding the review process. Institute of Medicine Committee on a Review of the California Institute for Regenerative Medicine open call on June 28, 2012.

IOM. 2012f.*Roundtable discussion of CIRM’s scientific impact. IOM Committee on a Review of the California Institute for Regenerative Medicine Subcommittee Meeting with Boston Stem Cell Scientists on June 26, 2012, Boston, MA.

Trounson, A., N. D. Natalie, and G. F. Ellen. 2012. The Alpha Stem Cell Clinic: A model for evaluating and delivering stem cell-based therapies. Stem Cells Translational Medicine 1:9-14.

References with an asterisk (*) are public access files. To access those documents, please contact The National Academies’ Public Access Records Office at (202)334-3543 or paro@nas.edu.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement